ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,249,000 | +1481.0% | 37,393 | +1104.7% | 0.01% | – |
Q4 2019 | $79,000 | -93.9% | 3,104 | -92.2% | 0.00% | -100.0% |
Q2 2019 | $1,286,000 | -21.2% | 39,888 | -21.3% | 0.01% | +33.3% |
Q1 2019 | $1,632,000 | -27.8% | 50,688 | -26.0% | 0.01% | -25.0% |
Q3 2018 | $2,260,000 | – | 68,542 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |